Expertise in
8
conditions

Dr. Mark E. Kutner

Internal Medicine
Office
10095 N Kendall Dr Ste 102, 
Miami, FL 
Accepting New Patients
Offers Telehealth
Expertise in
8
conditions
Office
10095 N Kendall Dr Ste 102, 
Miami, FL 

Overview

Mark Kutner is a primary care provider, practicing in Internal Medicine in Miami, Florida.

Dr. Kutner is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Chronic Pain, Purpura, Gardner-Diamond Syndrome, and Autoerythrocyte Sensitivity.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 31 clinical trials. Dr. Kutner is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in FL

Hospital Affiliations

South Miami Hospital
Homestead Hospital

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Office
10095 N Kendall Dr Ste 102, Miami, FL 33176

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

25 Clinical Trials

Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: July 17, 2024
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: November 30, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 22, 2023
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Osteoarthritis
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Osteoarthritis
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Terminated
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Chronic Low Back Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
View 9 Less Clinical Trials

2 Total Publications

Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.
Journal: medRxiv : the preprint server for health sciences
Published: August 17, 2021
Similar Doctors
Expertise in
6
conditions
Dr. Ravindra J. Ganesh
Internal Medicine
Expertise in
6
conditions
Dr. Ravindra J. Ganesh
Internal Medicine

Baptist Health Concierge Medicine | Coral Gables (Belmont Village)

4101 Salzedo St, 
Coral Gables, FL 
 (8.0 miles away)
786-345-7208
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Ravindra Ganesh is a primary care provider, practicing in Internal Medicine in Coral Gables, Florida. Dr. Ganesh is highly rated in 6 conditions, according to our data. His clinical expertise encompasses COVID-19, Long Haul COVID, Multisystem Inflammatory Syndrome in Children (MIS-C), and Severe Acute Respiratory Syndrome (SARS). Dr. Ganesh is currently accepting new patients.

Expertise in
59
conditions
Dr. Manuel A. Ojeda
Internal Medicine
Expertise in
59
conditions
Dr. Manuel A. Ojeda
Internal Medicine

Select Specialty Hospital-Miami

955 NW 3rd St, 
Miami, FL 
 (12.2 miles away)
305-416-5700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Manuel Ojeda is a primary care provider, practicing in Internal Medicine in Miami, Florida. Dr. Ojeda is highly rated in 59 conditions, according to our data. His clinical expertise encompasses Necrosis, Painful Swallowing, Swallowing Difficulty, Gastrostomy, and Endoscopy. Dr. Ojeda is currently accepting new patients.

Expertise in
29
conditions
Dr. Soroush Aghigh
Internal Medicine
Expertise in
29
conditions
Dr. Soroush Aghigh
Internal Medicine

Office

11605 SW 95th St, 
Miami, FL 
 (0.1 miles away)
305-407-1093
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Soroush Aghigh is a primary care provider, practicing in Internal Medicine in Miami, Florida. Dr. Aghigh is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Acute Coronary Syndrome, Necrosis, Stroke, Gastrostomy, and Colonoscopy. Dr. Aghigh is currently accepting new patients.

Frequently Asked Questions about Dr. Mark E. Kutner

How do I make an appointment with Dr. Mark E. Kutner?

You can book an appointment with Dr. Mark E. Kutner by calling their office at 305-595-5455. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark E. Kutner a top-rated expert for Chronic Pain?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark E. Kutner is classified as an Advanced expert for Chronic Pain, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark E. Kutner specialize in?

While Dr. Mark E. Kutner is a Internal Medicine, they have specific expertise in Chronic Pain, Purpura, and Gardner-Diamond Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Mark E. Kutner participate in research or clinical trials?

Yes. Dr. Mark E. Kutner has published 2 articles and abstracts on conditions like Chronic Pain. You can view a list of Dr. Mark E. Kutner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark E. Kutner accept my insurance?

Dr. Mark E. Kutner accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 305-595-5455 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kutner's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 198 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile